Patent Board Grants Inter Partes Review Of Arthritis Treatment Patent
(Decision available. Document #16-160620-016Z.)
The ruling came in response to a petition for inter partes review (IPR) by Coherus BioSciences Inc., which alleges invalidity of claims 1-4 of respondent Abbvie Biotechnology Ltd.’s U.S. patent No. 9,017,680. According to the board, the...
To view the full article, register now.